期刊文献+

急性冠脉综合征CD40-CD40L昼夜节律的变化 被引量:1

Circadian variation of CD40-CD40L system in patients with acute coronary syndrome
下载PDF
导出
摘要 目的观察血小板表达的白细胞分化抗原40及其配体系统(CD40-CD40L)在急性冠脉综合征(ACS)患者昼夜节律变化规律及其临床意义。方法选择40例正常对照组,40例不稳定心绞痛(UAP),30例急性心肌梗死(AMI)患者,在05∶00、10∶00分别抽取肘静脉血2ml,采用流式细胞仪测定血小板CD40、CD40L水平的变化。结果①UAP组和AMI组血小板CD40、CD40L较正常对照组高(P<0.05);②UAP组和AMI组05∶00CD40L较10∶00高(P<0.05),对照组两个时间点之间无显著差异;③3组血小板CD40两个时间点均无显著差异。结论ACS血小板表达的CD40及CD40L增高,且血小板CD40L呈现出昼夜节律的变化。 AIM To investigate whether there is a significant circadian variation of CD40 antigens and CD40 ligands (CD40Ls) on platelets in patients with acute coronary syndrome (ACS). METHODS The expressions of CD40 and CD40L on platelets at the time point of 05 : 00 and 10 : 00 were determined in 40 patients with unstable angina pcetoris (UPA), 30 patients with acute myocardial infarction (AMI) and in controls ( n = 40) by flow cytometry. RESULTS The expressions of CD40 and CD40L on platelets in UPA and AMI patients were significantly higher than those in controls (P 〈 0.01 ). The CD40L levels at 05 : 00 in UPA and AMI patients significantly increased compared to the levels at 10 : 00 (P 〈 0. 001 ) but no significant difference of CD40L on platelets was found in controls between 05:00 and 10 : 00. The CD40 expression on platelets at 05 : 00 was higher than that at 10 : 00, but no significant difference was found between controls and patients with ACS. CONCLUSION Patients with ACS show significantly increased coexpression of CD40 system and circadian variation at CD40L concentration on platelets.
出处 《心脏杂志》 CAS 2008年第6期725-727,共3页 Chinese Heart Journal
关键词 白细胞分化抗原40 急性冠脉综合征 流式细胞术 动脉粥样硬化 acute conorary syndrome flow cytometry cd40 antigens ed40 ligands artherosclerosis
  • 相关文献

参考文献8

  • 1Clodi K, Asgari Z, Younes M, et al. Expression of cd40 ligand (cd154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance [ J ]. Cancer, 2002, 94 ( 1 ) : 1 - 5.
  • 2Lutgens E, Daemen MJ. CD40-CD40L interactions in atherosclerosis [ J]. Trends Cardiovasc Med, 2002, 12( 1 ) :27 - 32.
  • 3Bavendiek U, Libby P, Kilbride M, et al. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nucler factor kappa B, and Egr-1 [ J ]. J Biol Chem, 2002, 277 ( 28 ) : 25032 - 25039.
  • 4Fuentes L, Hernandez M, Femandez-Aviles FJ, et al. Cooperation between secretory phospholipase A2 and TNF-reeeptor superfamily signaling: implications for the inflammatory response in atherogenesis[J]. Circ Res, 2002, 91(8) :681 -688.
  • 5Lee Y, Lee WH, Lee SC, et al. CD40L activation in circulating platelates in patients with acute coronary syndrome[ J]. Cardiology, 1999, 92(1) :11 -16.
  • 6Aukrust P, Muller F, Ueland T, et at. Enhancea levers of soluble and membrane-bound CD40 ligand in patients with unstable anginapossible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndrome [ J ]. Circulation, 1999, 100(6) :614 -620.
  • 7Mach F, Sehonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial ceils, smooth muscle cells and macrophages : implications for CD40-CD40 ligand signaling in atherosclerosis[ J]. Proc Natl Acad Sci U S A, 1997, 94(5) : 1931 - 1936.
  • 8Bruemmer D, Riggers U, Holzmeister J, et al. Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions[ J]. Am J Cardiol, 2001, 87(1) :21 -27.

同被引文献11

  • 1徐琳,李志梁,洪长江,何建新,马骏,向定成,张洁,潘春梅,邱健.B7相关蛋白-1在人冠状动脉内皮细胞的表达及临床意义[J].南方医科大学学报,2009,29(8):1623-1625. 被引量:2
  • 2Shoenfeld Y, Sherer Y, Harats D. Artherosclerosis as an infectious, inflammatory and autoimmune disease [ J ]. Trends lmmunol, 2001, 22(6) :293 -295.
  • 3Haimila KE, Partanen JA, Holopainen PM. Genetic polymorphismof the human ICOS gene[ J]. Immunogenetics, 2002, 53 ( 12 ) : 1028 - 1032.
  • 4Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion [J]. Circulation, 2000, 101 ( 13 ) : 1500 - 1502.
  • 5Asgary S, Saberi SA, Azampanah S. Effect of immunization against ox-LDL with two different antigens on formation and development of atherosclerosis[J]. Lipids Health Dis, 2007, 6:32 - 36.
  • 6Watanabe M, TakagiY, Kotani M, et al. Down-Regulation of ICOS Ligand by Interaction with ICOS Functions as a Regulatory Mechanism for Immune Responses[J]. J Immunol, 2008, 180(8) :5222 - 5234.
  • 7Gotsman I, Grabie N, DaCosta R, et al. The Role of the T-cell Inducible Co-stimulatory Molecule ICOS in the Development of Atherosclerosis [ J ]. FASEB J, 2006, 20 (3) : A199 - A205.
  • 8Asgary S, Saberi SA, Azampanah S. Effect of immunization against ox-LDL with two different antigens on formation and development of atherosclerosis[ J ]. Lipids Health Dis, 2007, 6(24) :32 - 38.
  • 9Lutgens E, Lievens D, Beckers L, et al. CD40 and its ligand in atheroselerosis[J]. Trends Cardiovase Med , 2007, 17(4) :118 -123.
  • 10徐琳,李志梁,朱肖星,马骏,洪长江,何建新,向定成,潘春梅,邱健.氧化低密度脂蛋白刺激人冠状动脉内皮细胞可诱导共刺激分子配体的表达[J].细胞与分子免疫学杂志,2009,25(9):819-821. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部